Tratamiento en Milán (Italia)

Dr. Bernhard Reimers – Clinical and Invasive Cardiology Unit Director in Humanitas Research Hospital, was born in Germany. He graduated in medicine and surgery in University of Padua (Italy) in 1990, followed by specialization in Cardiology. During the first 3 years of specialization in Cardiology in the Coronary Unit of Padua University, his particular interests were in managing cardiovascular urgency and critical patients, including management of fans, balloon pump, hemofiltration, temporary pacing, placement of central venous pathways and Swan-Ganz catheter. He spent his last year of specialization at the Hemodynamics of Casa di Cura Columbus (Milan), where he acquired his knowledge on the main diagnostic techniques he uses. After a short period of study at the Thoraxcenter of Rotterdam, during which he wrote his first scientific publications, Dr. Reimers has dedicated himself to hemodynamics and cardiovascular surgeries, working as Unit Director main assistant, executing angioplasty, coronary and peripheral procedures, reaching complete autonomy in coronary stenting, atherectomy, ultrasound intravascular and intracoronary doppler.

Since September 1997 he has managed and developed the diagnostic and interventional cardiovascular program at the Department of Cardiology of Mirano (Venice), where, thanks to his achievements, since 2000 the highest number of coronary angioplasties were performed. In 2006 the Unit has performed 975 coronary angioplasties (including 125 primary), more than 400 carotid angioplasty and peripherals. Dr. Reimers became Unit Director and has trained and taught a young team of interventional cardiologists, including 4 completely independent in the performance of coronary angioplasty, which manages both hemodynamics and largely the CCU in close collaboration between the two services. After this important experience, he was invited to be part of Humanitas Research Hospital as Clinical and Invasive Cardiology Unit Director.

Dr. Reimers participates in many scientific studies on the treatment of myocardial infarction considering new interventional or pharmaceutical approaches for primary angioplasty. He was also member of the Technical Commission of the Regional Bid for the purchase of stents. Thanks to Dr. Reimers’ efforts, Hemodynamics of Mirano (Venice) is considered reference center for primary angioplasty and elective complex procedures. Dr. Reimers is considered to be one of the leading experts of carotid angioplasty worldwide. He is preparing a program for interventional treatment of acute stroke. He performs routine renal angioplasty and implants percutaneous devices and endoprosthesis systems for aortic aneurysms.

Dr. Reimers has published, as author or co-author, 77 articles quoted in Medline. The impact factor calculated based on 2006 is 263. He published 9 book chapters and several abstracts for important international conferences dedicated to Cardiology, such as TCT, PCR, National GISE ANMCO, JIM and ESC, were he also performed live invasive procedures.

Dr. Reimers has always considered participation in clinical trials and scientific international events among the main activities of his professional carrier. Besides teaching at University of Tor Vergata in Rome, he organizes many conferences, national and international medical follow-up courses. For over 9 years he has been organizing theoretical and practical courses with lectures and transmission of live procedures in Venice. He has so far organized two editions of TOBI, international meeting dedicated to invasive treatment of total coronary occlusions and bifurcations, three editions of ETI, international conference and the largest in Italy, dedicated to invasive cardiology devices. 

Dr. Reimers was member of the scientific committee in the editions of 2006 and 2007 of National Convention GISE (Italian Group of Hemodynamic Study) and participated at important events dedicated to CAPTURE study, ESIRIUS, SYNTAX, TIMI 38, FINESSE and many others.

Publications: ttp://www.ncbi.nlm.nih.gov/pubmed/?term=bernhard

Prof. Marco Klinger is director of the School of Specialization in Plastic, Reconstructive and Aesthetic Surgery at the University of Milan and Head of the Operating Unit in Plastic, Reconstructive and Aesthetic Surgery at Humanitas Research Hospital.

He specializes in plastic and reconstructive surgery: treatment of scars, burns, outcomes of bariatric surgery, regenerative medicine and surgery, post-oncological breast reconstruction, breast malformations and skin oncology. Aesthetic plastic surgery: augmentation mammoplasty, mastopexy, reduction mammoplasty, rhinoplasty/ rhinoseptoplasty, lifting, liposuction, abdominoplasty, blepharoplasty and otoplasty.

Research interests: Regenerative medicine and surgery.

Prof. Klinger and his team have performed more than 35,000 plastic surgery and reconstructive surgery; he is the author of over 200 scientific articles, published in national and international journals. Among his most recent and significant studies, the use of lipofilling in treatment of severe burn outcome, scleroderma and chronic pain syndromes, such as Post Mastectomy Pain Syndrome.

Scientific publications: 

http://www.ncbi.nlm.nih.gov/pubmed?term=klinger%20marco

Prof. Andrea Lania has graduated at the Università degli Studi of Milan and is specialized in endocrinology. He is the Unit Director of Endocrinology and Diabetology in Humanitas Research Hospital and his specialization is pituitary diseases, pituitary adenomas, thyroid cancer, pancreatic neuroendocrine tumors, poorly differentiated neuroendocrine carcinomas.

Medical areas of interest:
Pituitary tumors, hypopituitarism, acromegaly, Cushing’s disease and syndrome, neuroendocrine tumors, thyroid and thyroid diseases, adrenal and adrenal diseases, hypogonadism.

Research areas of interest:
Study of the pathogenetic mechanisms of pituitary and neuroendocrine tumors, of the molecular mechanisms responsible for the different response of pituitary and neuroendocrine tumors to medical therapy.

Prof. Lania published 198 peer-reviewed papers (Google Scholar H-Index 47; Scopus H-Index 38, cit tot 4604)

Prof. Lania has a long standing expertise in the field of intra-cellular signaling in endocrine tumors. In particular, in the past ten years, he contributed to analyze the role of PKA regulatory subunits in the pathogenesis and control of cell proliferation of endocrine tumors. Moreover, he contributed to define the role of SSTR5 domains involved in the intracellular trafficking of this receptor in human pituitary cells and to analyze the impact of DR2R and SSTR2&5 polymorphic variants on both the clinical outcome and response to medical treatment in patients with pituitary tumors.

Recently, he contributed to identify the role of cytoskeleton protein FLNA in mediating both intracellular signaling and membrane targeting of somatostatin type 2 receptor and D2R in pituitary and pancreatic neuroendocrine tumors. Finally, he contributed to explore the intracellular mechanisms possibly involved in mediating the interplay between drugs commonly used in the treatment of neuroendocrine tumors.

Previous experience:
2005-2008 Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy
Director of Endocrinologic Day Hospital and surgery on pituitary disorders. 

Publications: https://www.ncbi.nlm.nih.gov/pubmed?term=lania%20A 

Prof. Alessandro Repici is the Director of the Gastroenterology and Digestive endoscopy Unit in Humanitas Research Hospital. Graduated in Medicine and Surgery in 1990 and the following year he won a scholarship at the Department of Gastroenterology Molinette hospital in Turin, where he began his practice in digestive endoscopy. In 1992, he worked with Prof. Claude Liguory as a fellow at the American Hospital in Paris.

In 1994 he became a specialist in Gastroenterology and Digestive Endoscopy at the University of Messina and worked in the Department of Gastroenterology, Ospedale Maggiore Molinette of Turin.

In the following years, he has been working at the Service of Digestive Endoscopy of Altona Hospital in Hamburg, directed by prof. Hagenmuller, and in the Department of Gastroenterology Molinette Hospital in Turin, directed by prof. Rizzetto. In 1999, he was a Research Fellow at the Center for Oncological and Operative Endoscopy of Wellsley Hospital in Toronto.

He teaches Gastroenterology and Digestive Endoscopy at the School of Specialization in Oncology since 2000, at the University of Turin since 2004 and Endoscopy Diagnostic Techniques and Operations at the School of Specialization in General Surgery I and II of the University of Turin.

The clinical activity and research of Prof. Repici mainly focuses on the development of new endoscopic techniques in the field of diagnosis and therapy, with particular attention to new methods of endoscopic removal of cancerous lesions and early in the palliation of advanced gastrointestinal malignancies.

Prof. Repici is coordinator, principal investigator and co-investigator in more than 50 studies, including phase II and III for FDA and EMA approval of new molecules and new instruments for diagnostic and operational endoscopy. 

Prof. Repici collaborates on research projects in the field of endoscopy with the University of Rotterdam, in Haifa, in New York and with several Italian centers. He is a member of various national and international scientific society of Gastroenterology and Digestive Endoscopy.

Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=repici+alessandro

Dr. Corrado Lodigiani has been assistant at the Thrombosis Centre of Humanitas research Hospital from 1998 to 2013 and he became Unit Director in 2013. 

Humanitas Thrombosis Center is a state-of-the-art service for the proper management of the diagnosis and therapy of venous thromboembolic pathology (deep and superficial venous thrombosis, pulmonary thromboembolism, visceral venous thrombosis) and arterial (myocardial infarction, cerebral stroke, peripheral arterial disease). 
Other also rare diseases treated are atypical thrombosis, such as the vascular circulation of the retina, the hearing system and the placental circulation during pregnancy. 

Dr. Lodigiani adopts the multidisciplinary approach and works in collaboration with all medical and surgical specialties. In particular, he carries out clinical and instrumental diagnostics (vascular ecocolordoppler) and research on the causes, diagnosis and therapy of thrombotic and bleeding disorders, congenital and acquired. His clinical activity also involves the diagnosis and management of patients suffering from bleeding diseases, such as haemophilia, von Willebrand’s disease and platelet diseases.

Medical areas of interest:  

In recent years, he has devoted himself with particular interest to the testing, in the role of Principal Investigator in International Clinical Studies, of new antithrombotic drugs and, above all, anticoagulants, which are about to be marketed and will constitute a valid and safe alternative to traditional oral anticoagulant therapy (DOACs). He is also working, with great interest, on researching the causes of idiopathic infertility and the usefulness and effectiveness of some therapeutic strategies, such as the use of anticoagulant drugs, improving the results of artificial insemination procedures. He is the author of numerous articles in international scientific journals and speaker at numerous national and international conferences.

Prof. Marco Montorsi is the Director of the Department of General and digestive surgery unit in Humanitas Research Hospital and he is Professor of General Surgery at the Humanitas University. His academic career started in the the Humanitas University of Milan, where he entered in 1980 as Assistant Professor and was appointed as Professor of Surgery in 2001.

His main interests are in the field of digestive diseases and in the surgical treatment of the related pathologies, mainly hepatico-pancreatico-biliary (HPB) and colorectal pathologies. He is indeed the Director of the Department of Surgery in Humanitas Research Hospital where a great volume of major abdominal surgeries is routinely performed. Around 250 -300 hepatic and pancreatic resections and 350 colorectal resections.
He began performing laparoscopic colorectal surgery in the early 90s and gained a lot of experience in this field. The vast majority of colorectal tumours diagnosed in the department of Surgery is submitted to laparoscopic resection thus allowing a smooth and safe disease course. A robotic approach with the new Da Vinci equipment is now available for patients with rectal tumours.

Transanal endoscopic microsurgery (TEM) with dedicated instruments is also offered to selected patient with low-sited rectal tumours so sparing major abdominal approach.

A routine policy of strict interaction with the Dept. of Oncology is active for patients needing a perioperative chemo- and radiotherapy with the aim of full integration for a better care and results.

Prof. Marco Montorsi is also Humanitas University President with over 10 years of experience in didactic and clinic teaching to medical students.

Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=montorsi+marco

Born in 1955, Prof. Paolo Emanuele Levi Setti graduated in Medicine and Surgery at the University of Milan School of Medicine in 1982 and specialized in Obstetrics and Gynaecology at the same University in 1988.

At the beginning of his career he was involved in the early developments of ultrasound imaging in obstetrics and gynaecology and more recently in the new applications of transvaginal and colour flow technology. From 1977 to 1982 microsurgery and endoscopy were his main interest in the investigation and treatment of female infertility.

Surgical applications in the animal model of new approaches to pelvic pathology were the first studies he published in literature. From 1985 to 1989 fetal blood sampling and prenatal diagnosis had a main role in his interest in research development. In this period, he participated in many published studies in this research area and one of the greatest experiences in the world was reported in the field of echographic surgery.

Results of in vitro fertilization, implantation, intrauterine embryo transfer, assisted reproduction in sexually transmitted diseases, evaluation of the uterine cavity in infertile patients and cryopreservation, are the main aspects of his present day scientific interest. In 1984, together with a group of colleagues, he founded one of the first centres in Italy operating in assisted reproduction. From 1988 to 1996 Prof. Levi Setti chaired the Infertility and Assisted Reproduction Unit of the Department of Obstetrics and Gynaecology – S. Paolo Biomedical Institute – University of Milan School of Italy operating in assisted reproduction. 

From 1989 to 1996 he coordinated the first European centre for assisted reproduction for HIV serodiscordant couples. Since 1994 he is a visiting lecturer at the 1st postgraduate School in Obstetrics and Gynecology and he is a visiting lecturer in the graduate course of Obstetrics and Gynaecology – University of Milan, School of Medicine.
Involved since the earliest development of endoscopy in gynaecology, he followed the evolution of this surgical approach performing, in over 25 years of activity, more than 15.000 procedures and mentoring an impressive number of fellows in this area. His Department has run for many years one of the largest ART programs in our country and in Europe. His research interest has, over the last few years, focused on the mechanisms of implantation, on the preservation of female and male fertility and on the complications and outcome of assisted reproduction. His Department performed the probably larger number of oocyte’s freezing procedures in infertile patients in Europe and is now a recognised expert in fertility preservation in oncological and fertility deferring patients. He has been the scientific organizer of several international meetings and training courses in Reproductive Medicine. 

Member of many international institutions in the field of reproductive medicine (American Society for Reproductive Medicine, European Society of Human Reproduction and Embryology, International Society for Fertility Preservation), he was elected President of the Italian Fertility and Sterility Society (SIFES e MR) onto the board in 1999 and in 2003 and for two mandates (2009-2001 and 2011-2013). 

He is the author of more than 100 published articles, reviews and chapters in books. 

From 2004 Prof. Levi Setti collaborates with the Italian Ministry of Health in revising data of the National Medically Assisted Reproduction Register. In December 2010 he was nominated scientific coordinator of an experimental project for an ART Network in Lombardy County. Since 1996 Prof. Levi Setti works at the Humanitas Research Hospital in Milan and is currently chair of the Department of Gynaecology and heads the Division of Gynaecology and Reproductive Medicine. In May 2011 he was appointed, for the period July 2011- June 2016, as Adjunct Professor at Yale University, School of Medicine. In June 2013 he supervised and is actually personally directing the Humanitas Fertility Center, where over 3.500 ART procures are performed annually.

Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=levi sett